LCMV gp33 peptide KAVYNFATM (H-2 Db)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
LCMV gp33 peptide KAVYNFATM (H-2 Db)

LCMV gp33 peptide KAVYNFATM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from lymphocytic choreomeningitis virus (LCMV) glycoprotein 33 (gp33) is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: KAVYNFATM
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: H-2 Db

Podobne produkty

CD3/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

CD3/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; BKV LT-antigen (LLLIWFRPV)

MHC I-Strep HLA-A*0201; BKV LT-antigen (LLLIWFRPV)

IBA Lifescience
Więcej
SARS-CoV-2 peptide ALNTLVKQL (HLA-A*0201)

SARS-CoV-2 peptide ALNTLVKQL (HLA-A*0201)

IBA Lifescience
Więcej